Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 66 Lymphoma 35 Neutropenia 30 Lymphoma, Large B-Cell, Diffuse 23 Lymphoma, Non-Hodgkin 18 Neoplasms 15 Carcinoma, Non-Small-Cell Lung 14 Ovarian Neoplasms 13 Hodgkin Disease 13 Sarcoma 11 Multiple Myeloma 11 Lymphoma, Mantle-Cell 10 Lymphoma, Follicular 10 Leukemia 10 Burkitt Lymphoma 10 Precursor Cell Lymphoblastic Leukemia-Lymphoma 9 Lung Neoplasms 9 Triple Negative Breast Neoplasms 8 Rhabdomyosarcoma 7 Leukemia, Lymphocytic, Chronic, B-Cell 7 Chemotherapy-induced Neutropenia 7 Central Nervous System Neoplasms 6 Breast Neoplasms, Male 6 Testicular Neoplasms 5 Prostatic Neoplasms 5 Neoplasm Metastasis 5 Lymphoma, B-Cell, Marginal Zone 5 Febrile Neutropenia 5 Fallopian Tube Neoplasms 5 Carcinoma, Ovarian Epithelial 5

Interventions

Trastuzumab 33 pertuzumab 18 Docetaxel 16 pyrotinib 15 Paclitaxel 7 Capecitabine 6 tucatinib 5 Carboplatin 5 Ado-Trastuzumab Emtansine 4 trastuzumab deruxtecan 3 neratinib 3 atezolizumab 2 Protons 2 Neoadjuvant Therapy 2 Fulvestrant 2 pegfilgrastim 1 palbociclib 1 margetuximab 1 liposomal doxorubicin 1 inavolisib 1 exemestane 1 envafolimab 1 dalpiciclib 1 Taxoids 1 Metformin 1 Leuprolide 1 Letrozole 1 Isovaleryl-CoA Dehydrogenase 1 Injections 1 Hospital Information Systems 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

HER2-positive Breast Cancer × pegfilgrastim × Clear all

NCT03571633 2025-11-26

BREASTIMMU02

Centre Leon Berard

Phase 2 Active not recruiting

HER2-positive Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡